Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Respir Res ; 18(1): 197, 2017 Nov 28.
Article in English | MEDLINE | ID: mdl-29179729

ABSTRACT

BACKGROUND: Based on the phenotypic and functional characteristics unconventional T-lymphocytes such as invariant natural killer T (iNKT) cells and mucosal-associated invariant T (MAIT) cells link the innate and adaptive immune responses. Up to now data are scarce about their involvement in pulmonary disorders including chronic obstructive pulmonary disease (COPD). This study explores simultaneously the frequencies of iNKT and MAIT cells in the peripheral blood and sputum of stable and exacerbating COPD patients. METHODS: By means of multicolor flow cytometry frequencies of total iNKT and MAIT cells and their subsets were enumerated in peripheral blood and sputum samples of healthy controls, and COPD patients. In addition, gene expression of TCR for iNKT, MAIT cells, and CD1d, MR1 were assessed by qPCR in the study cohorts. RESULTS: Percentages of total iNKT and MAIT cells were dramatically dropped in blood, and reduced numbers of iNKT cells were observed in the sputum of COPD patients. Furthermore decreased DN and increased CD4+ iNKT subsets, while increased DN and decreased CD8+ MAIT subpopulations were measured in the blood of COPD patients. Reduced invariant TCR mRNA levels in COPD patients had confirmed these previous findings. The mRNA expression of CD1d and MR1 were increased in stable and exacerbating COPD patients; however both molecules were decreased upon antibiotic and systemic steroid treatments. CONCLUSIONS: Our results support the notion that both invariant T-cell populations are affected in COPD. Further detailed analysis of invariant T cells could shed more light into the complex interactions of these lymphocyte groups in COPD pathogenesis.


Subject(s)
Mucosal-Associated Invariant T Cells/metabolism , Natural Killer T-Cells/metabolism , Pulmonary Disease, Chronic Obstructive/blood , Adult , Female , Flow Cytometry/methods , Humans , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Male , Middle Aged , Mucosal-Associated Invariant T Cells/immunology , Natural Killer T-Cells/immunology , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/immunology , Sputum/immunology , Sputum/metabolism
2.
Orv Hetil ; 157(44): 1762-1768, 2016 Oct.
Article in Hungarian | MEDLINE | ID: mdl-27796130

ABSTRACT

INTRODUCTION: Studies on well-being of students in higher education are in the centre of international research interest, because adult health as a value plays an important role in the life of future generation. AIM: The authors studied variables that affect the value of well-being (satisfaction with life, student success, satisfaction with academic infrastructure, sports and financial situation of parents) among medical and health science students starting their studies. METHOD: The Hungarian version of the Word Health Organization WBI-5 (General Well-Being Index, 5-item version) were used. This questionnaire has a high internal reliability (Cronbach's alpha: 0.778). RESULTS: The unrotated principal component analysis of the questionnaire survey confirmed the homogeneity of the database utility (Kaiser-Meyer-Olkin-index = 0.748; Bartlett test<0.0001). On the basis of stepwise linear regression (R = 0.458, R2 = 0.21, F = 16.33, p = 0.001, VIF values around 1) showed (i) a positive relationship with explanatory variables such as faculty and sport activity, satisfaction with life scale and university infrastructure, and (ii) a negative relationship with gender and parental substance. CONCLUSION: The authors conclude that short Well-Being Index is a reliable and valid instrument to measure positive quality of life of medical students. Furthermore, the Well-Being Index can help university faculties and lecturers to deploy the student facilities and to eliminate the harm of stress situations. Orv. Hetil., 2016, 157(44), 1762-1768.


Subject(s)
Quality of Life/psychology , Students, Medical/psychology , Surveys and Questionnaires/standards , Education, Medical, Undergraduate/methods , Female , Humans , Male , Psychometrics , Students, Medical/statistics & numerical data , Young Adult
3.
Pathol Oncol Res ; 22(4): 755-61, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27105879

ABSTRACT

In the last decades new therapeutic drugs have been developed for the treatment of non-small cell lung cancer (NSCLC) patients. Tyrosine kinase inhibitors (TKIs) significantly increase the progression free survival (PFS) of patients with NSCLC carrying epidermal growth factor receptor (EGFR) mutations. This type of lung cancer occurs mainly among non-smoking women and Asian origin. However, the new ESMO guideline recommends EGFR mutation analysis in every patient with NSCLC, because in patients with activating EGFR mutation, TKIs should be considered as first line therapy. In our recent work, we analyzed data of patients with EGFR-mutant adenocarcinoma from January 2009. The number of patients investigated was 446, among them 44 cases were positive for EGFR mutation. The ratio of positive cases was 9.86 % that is lower than the average mutation rate in Europe and much lower than that found in Asia. The exon 19 deletion was detected in 61.4 % of the patients, while L858R point mutation in exon 21 was observed in 34.1 % of them. In one subject, both exon 19 and 21 mutations were present simultaneously. A rare mutation located in exon 21 was found in another patient. TKI therapy was conducted in 38 patients. The disease control rate by TKI therapy was 85.7 %; primary resistance was documented in five subjects. Non-smoking patients with EGFR mutant adenocarcinoma had the highest benefit from TKI treatment. Our data support the recommendation that EGFR mutation status should be defined in all cases of locally advanced or metastatic lung adenocarcinoma.


Subject(s)
Adenocarcinoma/drug therapy , Adenocarcinoma/genetics , ErbB Receptors/genetics , Lung Neoplasms/drug therapy , Lung Neoplasms/genetics , Mutation/genetics , Protein Kinase Inhibitors/therapeutic use , Adenocarcinoma of Lung , Aged , Antineoplastic Agents/therapeutic use , Exons , Female , Humans , Hungary , Male , Middle Aged , Mutation/drug effects , Protein-Tyrosine Kinases/metabolism
4.
Orv Hetil ; 154(32): 1269-76, 2013 Aug 11.
Article in Hungarian | MEDLINE | ID: mdl-23916908

ABSTRACT

INTRODUCTION: Electronic exams have been used at Semmelweis University within Health Care Informatics courses since 2006. The statistical analysis of the electronic exam sheets enabled the authors to assess the reliability of examinations, as well as recommend important measures to increase the quality and efficiency of knowledge transfer. AIM: The main objective of the study was to propose an optimal teaching methodology with a special focus on electronic exams, based on the statistical analysis of databases of electronic exams recorded at Health Care Informatics courses of Semmelweis University. METHOD: All data were analysed with statistical methods at the level of individual questions as well as exam results of each student (2801 medical students have undertaken 4933 electronic exams since 2006). Results were evaluated based on teaching methodology criteria. RESULTS: There was a significantly increased tendency in grades obtained at individual exams. The authors identified exam questions that are needed to be modified or even ignored, because they failed to correlate with the knowledge measurement of the students. CONCLUSIONS: Statistical analysis of exam results proved to be a useful tool to assess methodology of teaching, knowledge transfer, and their practical implications. It is essential to monitor continuously exam results, this may exert a significant impact on the improvement of the quality and efficiency of knowledge transfer processes.


Subject(s)
Education, Medical , Medical Informatics/education , Professional Competence , Teaching/methods , Computers , Education, Medical/methods , Education, Medical/organization & administration , Education, Medical/standards , Education, Medical/trends , Efficiency , Humans , Professional Competence/standards , Universities
5.
Environ Sci Technol ; 46(7): 4166-73, 2012 Apr 03.
Article in English | MEDLINE | ID: mdl-22432789

ABSTRACT

Little is known about the potential threats of silver nanoparticles (AgNPs) to ecosystem health, with no detailed report existing on the stress and immune responses of soil invertebrates. Here we use earthworm primary cells, cross-referencing to human cell cultures with a particular emphasis on the conserved biological processes, and provide the first in vitro analysis of molecular and cellular toxicity mechanisms in the earthworm Eisenia fetida exposed to AgNPs (83 ± 22 nm). While we observed a clear difference in cytotoxicity of dissolved silver salt on earthworm coelomocytes and human cells (THP-1 cells, differentiated THP-1 cells and peripheral blood mononuclear cells), the coelomocytes and differentiated (macrophage-like) THP-1 cells showed a similar response to AgNPs. Intracellular accumulation of AgNPs in the coelomocytes, predominantly in a phagocytic population, was evident by several methods including transmission electron microscopy. Molecular signatures of oxidative stress and selected biomarker genes probed in a time-resolved manner suggest early regulation of oxidative stress genes and subsequent alteration of immune signaling processes following the onset of AgNP exposure in the coelomocytes and THP-1 cells. Our findings provide mechanistic clues on cellular innate immunity toward AgNPs that is likely to be evolutionarily conserved across the animal kingdom.


Subject(s)
Biological Evolution , Immunity/drug effects , Metal Nanoparticles/toxicity , Oligochaeta/drug effects , Oligochaeta/immunology , Silver/toxicity , Stress, Physiological/drug effects , Animals , Cell Death/drug effects , Cell Line , Female , Gene Expression Regulation/drug effects , Humans , Immunity/genetics , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/metabolism , Male , Metal Nanoparticles/ultrastructure , Reactive Oxygen Species/metabolism , Stress, Physiological/genetics , Time Factors
6.
Orv Hetil ; 151(36): 1455-60, 2010 Sep 05.
Article in Hungarian | MEDLINE | ID: mdl-20739263

ABSTRACT

The concentration of deuterium is about 150 ppm (over 16 mmol/L) in surface water and more than 10 mmol/L in living organisms. Experiments with deuterium depleted water (30+/-5 ppm) revealed that due to D-depletion various tumorous cell lines (PC-3, human prostate, MDA, human breast, HT-29, human colon, M14, human melanoma) required longer time to multiply in vitro. DDW caused tumor regression in xenotransplanted mice (MDA and MCF-7, human breast, PC-3) and induced apoptosis in vitro and in vivo. Deuterium depleted water (25+/-5 ppm) induced complete or partial tumor regression in dogs and cats with spontaneous malignancies, it was registered as anticancer for veterinary use in 1999 (Vetera-DDW-25 A.U.V., 13/99 FVM). The hypodermic preparation of the registered veterinary drug was successfully tested in clinical investigations. Under the permission of the Hungarian Institute of Pharmacology (No. 5621/40/95) a randomized, double blind controlled, human Phase II clinical trial with prostate cancer was performed, in compliance with GCP principles, which exhibited a significant difference between the control and treated groups with respect to the examined parameters, median survival time and the extension of life-span. We suggest that cells are able to regulate the D/H ratio and the changes in the D/H ratio can trigger certain molecular mechanisms having a key role in cell cycle regulation. We suppose that not the shift in the intracellular pH, but the concomitant increase in the D/H ratio is the real trigger for the cells to enter into S phase. The decrease of D concentration can intervene in the signal transduction pathways thus leading to tumor regression. Deuterium depletion may open new perspectives in cancer treatment and prevention helping to increase the effectiveness of current oncotherapies.


Subject(s)
Apoptosis/drug effects , Deuterium/pharmacology , Neoplasms/drug therapy , Animals , Breast Neoplasms/drug therapy , Cats , Cell Line, Tumor , Clinical Trials, Phase II as Topic , Colonic Neoplasms/drug therapy , Deuterium Exchange Measurement , Dogs , Female , Humans , Male , Melanoma/drug therapy , Mice , Neoplasms/pathology , Prostatic Neoplasms/drug therapy , Randomized Controlled Trials as Topic , Remission Induction , Signal Transduction/drug effects , Skin Neoplasms/drug therapy , Survival Analysis , Time Factors , Transplantation, Heterologous , Treatment Outcome
7.
Immunobiology ; 215(7): 521-6, 2010 Jul.
Article in English | MEDLINE | ID: mdl-19906460

ABSTRACT

In the last decade new glucocorticoid (GC)-signalling mechanisms have emerged. The evolving field of non-genomic GC actions was precipitated from two major directions: (i) some rapid/acute clinical GC applications could not be explained based on the relatively slowly appearing genomic GC action and (ii) accumulating evidence came to light about the discrepancy in the apoptosis sensitivity and GR expression of thymocytes and other lymphoid cell types. Herein, we attempt to sample the latest information in the field of non-genomic GC signalling in T cells, and correlate it with results from our laboratory. We discuss some aspects of the regulation of thymocyte apoptosis by GCs, paying special interest to the potential role(s) of mitochondrial GR signalling. The interplay between the T cell receptor (TcR) and glucocorticoid receptor (GR) signalling pathways is described in more detail, focusing on ZAP-70, which is a novel target of rapid GC action.


Subject(s)
Glucocorticoids/pharmacology , Mitochondria/metabolism , Receptors, Antigen, T-Cell/metabolism , Receptors, Glucocorticoid/metabolism , ZAP-70 Protein-Tyrosine Kinase/metabolism , Animals , Apoptosis/drug effects , Apoptosis/immunology , Genome , Humans , Receptors, Antigen, T-Cell/immunology , Receptors, Glucocorticoid/immunology , Signal Transduction/immunology , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , T-Lymphocytes/pathology , Thymus Gland/immunology , Thymus Gland/pathology
8.
Int Immunol ; 21(11): 1269-76, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19737783

ABSTRACT

Glucocorticoid receptor (GR) signaling plays an important role in the selection and apoptosis of thymocytes. Besides nuclear translocation, mitochondrial translocation of the ligand-bound GR in lymphoid cells was also shown, which might determine glucocorticoid (GC)-induced apoptosis sensitivity. In the present work, we followed the ligand-induced GR trafficking in CD4+CD8+ double-positive (DP) thymocytes. Using confocal microscopy, we found that upon short-term in vitro GC analog [dexamethasone (DX)] treatment, the GR translocates into the mitochondria but not into the nucleus in DP cells. We also analyzed the GR redistribution in cytosolic, nuclear and mitochondrial fractions of unseparated thymocytes by western blot and confirmed that in DX-treated cells a significant fraction of the GR translocates into the mitochondria. DX reduced the mitochondrial membrane potential of DP cells within 30 min, measured by flow cytometry, which refers to a direct modulatory activity of mitochondrial GR translocation. The abundant mitochondrial GR found in DP cells well correlates with their high GC-induced apoptosis sensitivity.


Subject(s)
Apoptosis/drug effects , Mitochondria/metabolism , Receptors, Glucocorticoid/metabolism , T-Lymphocytes/immunology , Thymus Gland/immunology , Animals , Apoptosis/immunology , Cell Line, Tumor , Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Membrane Potential, Mitochondrial/drug effects , Mice , Mice, Inbred BALB C , Mitochondria/drug effects , T-Lymphocytes/drug effects
9.
Biochem Biophys Res Commun ; 354(1): 253-8, 2007 Mar 02.
Article in English | MEDLINE | ID: mdl-17222799

ABSTRACT

The glucocorticoid receptor (GR) participates in both genomic and non-genomic glucocorticoid hormone (GC) actions by interacting with other cytoplasmic signalling proteins. Previously, we have shown that high dose Dexamethasone (DX) treatment of Jurkat cells causes tyrosine phosphorylation of ZAP-70 within 5 min in a GR-dependent manner. By using co-immunoprecipitation and confocal microscopy, here we demonstrate that the liganded GR physically associates with ZAP-70, in addition to its phosphorylation changes. The association of the ligand-bound GR and ZAP-70 was also observed in HeLa cells transfected with ZAP-70, suggesting that this co-clustering is independent of lymphocyte specific factors. Furthermore, the ZAP-70 was found to also co-precipitate with Hsp-90 chaperone both in Jurkat and transgenic HeLa cells, independent of the presence of DX. These findings raise the possibility that ZAP-70 may serve as an important link between GC and TcR-induced signaling, thereby transmitting non-genomic GC action in T-cells.


Subject(s)
HSP90 Heat-Shock Proteins/metabolism , Receptors, Glucocorticoid/metabolism , Subcellular Fractions/metabolism , ZAP-70 Protein-Tyrosine Kinase/metabolism , HeLa Cells , Humans , Jurkat Cells , Protein Binding
10.
J Steroid Biochem Mol Biol ; 98(2-3): 147-54, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16406604

ABSTRACT

Steroid hormones are known to mediate rapid non-genomic effects occurring within minutes, besides the classical genomic actions mediated by the nuclear translocation of the cytoplasmic glucocorticoid receptor (GR). The glucocorticoid hormone (GC) has significant role in the regulation of T-cell activation; however, the cross-talk between the GC and T-cell receptor (TcR) signal transducing pathways are still to be elucidated. We examined the rapid effects of GC exposure on in vitro cultured human T-cells. Our results showed that Dexamethasone (DX), a GC analogue, when applied at high dose (10 microM), induced rapid (within 5 min) tyrosine-phosphorylation events in Jurkat cells. Short DX pre-treatment strongly inhibited the tyrosine-phosphorylation stimulated by CD3 cross-linking. Furthermore, we also investigated the phosphorylation status of ZAP-70, an important member of tyrosine kinase mediated signalling pathway of TcR-elicited T-cell activation. Here, we demonstrate that high dose DX induced a rapid ZAP-70 tyrosine-phosphorylation in Jurkat T-cells. DX-induced ZAP-70 phosphorylation could be inhibited by RU486 (GR antagonist), suggesting that this process was GR mediated. DX-induced ZAP-70 phosphorylation did not occur in the absence of active p56-lck as examined in the p56-lck kinase-deficient Jurkat cell line JCaM1.6. Our results show that DX, at a high dose, can rapidly influence the initial tyrosine-phosphorylation events of the CD3 signalling pathway in Jurkat cells, thereby modifying TcR-derived signals. Lck and ZAP-70 represent an important molecular link between the TcR and GC signalling pathways.


Subject(s)
Dexamethasone/pharmacology , Signal Transduction/drug effects , Tyrosine/metabolism , ZAP-70 Protein-Tyrosine Kinase/metabolism , CD3 Complex/metabolism , Dexamethasone/metabolism , Humans , Jurkat Cells , Kinetics , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/metabolism , Mifepristone/metabolism , Mifepristone/pharmacology , Phosphorylation , Receptors, Glucocorticoid/metabolism , T-Lymphocytes/metabolism , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...